PXYN — Praxsyn Share Price
Last trade - 00:00- $0.00m
- $2.92m
- $66.60m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | 0.14 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 246.29% | ||
| Return on Equity | 159.9% | ||
| Operating Margin | 33.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015E | 2016E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.35 | 1.58 | n/a | 6.99 | 66.6 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Praxsyn Corporation is a holding company. The Company operates through its subsidiaries, Mesa Pharmacy, Inc. (Mesa) and Nevada Health RX, Inc (NHRX). Through Mesa, the Company focuses on administration and collection of its portfolio of Workers Compensation (WC) accounts receivable. Through NHRX, the Company markets medical supplies through direct sales to medical practitioners. Through Praxsyn Capital Corporation (PraxCapita), the Company provides revenue cycle management solutions for healthcare providers focusing on Personal Injury (PI) and WC. Through Praxsyn Medical Inc., the Company is engaged in retail pharmacy and medical supplies and equipment.
Directors
- Frank Brady CHM (43)
- Daniel Oswald CFO
- Amy Summers OTH
- Daniel Barretto DRC (55)
- Sanjeev Kaila DRC (46)
- Thomas Patire DRC
- Greg Sundem DRC (53)
- Last Annual
- December 31st, 2014
- Last Interim
- September 30th, 2015
- Incorporated
- June 6th, 2005
- Public Since
- September 5th, 2007
- No. of Employees
- 6
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 788,742,157
- Address
- 7904 E Chaparral Rd, Ste A110-210, SCOTTSDALE, 85250
- Web
- https://praxsyn.com
- Phone
- +1 7027613809
- Auditors
- dbbmckennon
Upcoming Events for PXYN
Similar to PXYN
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
As of Today at 22:44 UTC, shares in Praxsyn are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Praxsyn last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Praxsyn share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out morePraxsyn does not currently pay a dividend.
Praxsyn does not currently pay a dividend.
Praxsyn does not currently pay a dividend.
To buy shares in Praxsyn you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Praxsyn had a market capitalisation of $0.00m.
Here are the trading details for Praxsyn:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PXYN
Based on an overall assessment of its quality, value and momentum Praxsyn is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Praxsyn. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.00, shares in Praxsyn were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Praxsyn PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Praxsyn's management team is headed by:
- Frank Brady - CHM
- Daniel Oswald - CFO
- Amy Summers - OTH
- Daniel Barretto - DRC
- Sanjeev Kaila - DRC
- Thomas Patire - DRC
- Greg Sundem - DRC